(INNS)
[90 Y]YTTRIUM CLIVATUZUMAB TETRAXETAN(INND)
YTTRIUM-(90Y) KLIVATUZUMAB TETRAXETAN(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS MUC1 (MUCIN 1, POLYMORPHIC EPITHELIAL MUCIN, PEM, CD227)], HUMANIZED MONOCLONAL ANTIBODY, YTTRIUM (90Y) RADIOLABELLED TETRAXETAN CONJUGATE; GAMMA1 HEAVY CHAIN (1-449) [HUMANIZED VH (HOMO SAPIENS IGHV1-2*02 (79.60%) -(IGHD)-IGHJ4*01) [8.8.12] (1-119) -HOMO SAPIENS IGHG1*03 (120-449)], (222-215')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-215') [HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-13*02 (78.90%) -IGKJ2*01) [7.3.9] (1'-108') -HOMO SAPIENS IGKC*01 (109'- 215')]; (228-228":231-231")-BISDISULFIDE DIMER; YTTRIUM (90Y) RADIOLABELLED TETRAXETAN (DOTA) CONJUGATE, RECOMMENDED INN: LIST 64(WHO)
YTTRIUM (90Y) CLIVATUZUMABUM TETRAXETANUM(INN)